TipRanks
Go Ultimate55% OFF

Mirion Technologies (MIR) AI Stock Analysis

MX:MIR

Mirion Technologies

(BMV:MIR)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Backlog VisibilityThe sharp backlog increase provides meaningful revenue visibility beyond the current quarter and supports planning for the next several periods. Higher future-year backlog and 95% revenue coverage reduce reliance on near-term order timing, while supporting sustained growth and operating leverage.
Negative Factors
Margin PressureWithdrawal of the near-term 30% margin target shows that profitability improvement may take longer than previously expected. Medical growth moderation, slower Paragon margin expansion, and front-loaded AI and cybersecurity spending can limit operating leverage and constrain earnings growth over the next several periods.

Mirion Technologies (MIR) vs. SPDR S&P 500 ETF (SPY)

-50%-40%-30%-20%-10%0%10%20%MX:MIR-43.91%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 4.47B
Dividend Yield
―
Average Volume (3M)
3,720
Price to Earnings (P/E)
158.2
Beta (1Y)
0.07
Revenue Growth
7.31%
EPS Growth
-11.94%
Country
Mexico
Employees
3,281
Sector
Industrials
Sector Strength
63
Industry
Industrial - Machinery

Mirion Technologies Business Overview & Revenue Model

Company Description

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized soluti...

Mirion Technologies Earnings Call Summary

Earnings Call Date:Oct 26, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Feb 15, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Highlights included substantial order growth, expanding backlog, higher revenue and EBITDA, raised revenue and free cash flow guidance, strong nuclear and SMR momentum, and improved cash generation. The main challenges were margin pressure, withdrawal of the near-term 30% margin target, uneven medical-market conditions, AI-related front-loaded spending, and the need to reduce leverage below 3.0x by year end. Management remained constructive about fourth-quarter acceleration and the outlook for 2027.

Positive Updates

Strong Order Growth
Third-quarter orders increased 62% year over year excluding M&A to $340 million, led by the nuclear power end market, where orders increased 105% excluding M&A. Total orders, including $46 million from Paragon and Certrec, increased 85% to $386 million despite the previously discussed Chinese debooking.

Negative Updates

Near-Term 2028 Margin Target Withdrawn
Mirion said its previously announced 2028 margin target is now too aggressive and removed the near-term 30% EBITDA margin target. Management cited tempered medical organic growth, margin expansion at Paragon running behind initial expectations, and significant front-loaded investment in AI and cybersecurity.

Company Guidance

Mirion guided to 2026 total revenue growth of 24% to 25%, organic revenue growth of 7% to 8%, fourth quarter consolidated organic revenue growth in the mid- to high-teens, medical growth of mid single digits plus, and nuclear and safety including Paragon's December results growth of high teens plus; adjusted EBITDA is expected at $285 million to $292 million, with margins of approximately 24.7% to 25.2%, adjusted free cash flow at $170 million to $185 million, representing 60% to 63% conversion of adjusted EBITDA, and adjusted EPS between $0.50 to $0.54 per share, using a fourth €0.25 to dollar rate of 1.12. The company expects nuclear power to deliver double digit organic revenue growth for the full year, Paragon to achieve at least 25% year-over-year growth, net leverage to improve to approximately 2.6x by year end at the midpoint assuming no fourth quarter share repurchases or M&A, and annual margin expansion of 1 to 2 points; AI operating expense is expected to be 5 or above for the year, to grow some next year, and AI-related CapEx is expected to be less than what is been expense through this year and probably grows a bit next year.

Mirion Technologies Risk Analysis

Mirion Technologies disclosed 47 risk factors in its most recent earnings report. Mirion Technologies reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

2 New Risks
1.Conversion of our Convertible Notes may dilute the ownership interest of our stockholders or may otherwise depress the price of our Class A common stock.Q3, 2025
2.The conditional conversion feature of our Convertible Notes, if triggered, may adversely affect our financial condition and operating results.Q3, 2025

Mirion Technologies Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

MX:MIR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
GHMGHM62Neutral$821.01M65.997.99%―21.22%-16.93%
BWBW52Neutral$636.08M-4.9177.75%―40.37%55.59%
HDRNHDRN44Neutral$47.20M1.9619.98%――99.04%
XEXE42Neutral$4.44B-13.33-24.06%―――

* Industrials Sector Average

Performance Comparison

0%200%400%MX:MIRBWGHMHDRNXEFISNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:MIR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:MIRMirion Technologies, Inc.280.17-219.33-43.91%
BWBabcock & Wilcox4.270.358.93%
GHMGraham Corporation69.957.6712.32%
HDRNHadron Energy, Inc.0.66-10.05-93.84%
XEX-Energy, Inc. Class A10.93-18.27-62.57%
FISNDeep Fission, Inc.2.67-11.89-81.66%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.